Pii Expands Sterile Fill-Finish Capacity and Capabilities

Increases its ability to perform Large Volume Sterile Fill-Finish production needed for manufacturing most vaccinations.

Author Image

By: Charlie Sternberg

Associate Editor

Pii has strategically invested in an expansion of its sterile fill-finish capacity and capabilities, with production lines capable of supporting large commercial scale batch sizes. Specifically, Pii has increased its investment in the Bosch Aseptic Filling Line, increasing the ability to perform Large Volume Sterile Fill-Finish production needed for manufacturing most vaccinations.   “Over the last year we have seen many vaccinations to tackle the Covid-19 pandemic. With the CDC now recommending...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters